Literature DB >> 15665717

Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.

Birger Trollfors1, John Taranger, Teresa Lagergård, Valter Sundh.   

Abstract

The effect of pertussis toxoid on the immunogenicity of diphtheria and tetanus toxoids (DT) was studied during a double blind efficacy trial of an acellular pertussis vaccine. Infants received DT with or without pertussis toxoid at 3, 5 and 12 months of age. Geometric mean concentrations were higher in the DT than in the DT-pertussis toxoid group 1 month (diphtheria toxoid 4.76 versus 3.58 IU/mL, P = 0.009; tetanus toxoid 4.42 versus 2.66 IU/mL, P < 0.0001) and 2 years after the third injection (diphtheria toxoid 0.15 versus 0.10 IU/mL, P < 0.0001; tetanus toxoid 0.38 versus 0.18 IU/mL, P < 0.0001). Pertussis toxoid causes a small but significant reduction of the immunogenicity of diphtheria toxoid and tetanus toxoid.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665717     DOI: 10.1097/01.inf.0000148929.91719.10

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  A study of physico-chemical interactions between Haemophilus influenzae type b and meningococcus group C conjugate vaccines.

Authors:  Robert B D Otto; Dennis T Crane; Barbara Bolgiano
Journal:  Afr Health Sci       Date:  2007-12       Impact factor: 0.927

2.  Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.

Authors:  Birger Trollfors; Nina Knutsson; John Taranger; Anders Mark; Elisabet Bergfors; Valter Sundh; Teresa Lagergård
Journal:  Eur J Pediatr       Date:  2005-10-26       Impact factor: 3.183

3.  Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.

Authors:  Anna D LoBue; Joseph M Thompson; Lisa Lindesmith; Robert E Johnston; Ralph S Baric
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

4.  Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs.

Authors:  Tilo Senger; Lysann Schädlich; Sonja Textor; Corinna Klein; Kristina M Michael; Christopher B Buck; Lutz Gissmann
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641

5.  Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines.

Authors:  Suzanne M Garland; Marc Steben; Mauricio Hernandez-Avila; Laura A Koutsky; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Mark T Esser; Scott C Vuocolo; Micki Nelson; Radha Railkar; Carlos Sattler; Eliav Barr
Journal:  Clin Vaccine Immunol       Date:  2007-04-11

6.  Rocket and Two Dimensional Immunoelectrophoresis in Diagnosis of Caprine Brucellosis.

Authors:  Davood Mehrabani; Zahra Gholami; Jamshid Kohanteb; Masood Sepehrimanesh; Seyed Mohammad Hossein Hosseini
Journal:  Iran J Public Health       Date:  2015-08       Impact factor: 1.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.